Vancomicina intraósea en artroplastía total de rodilla
Acta Ortopédica Mexicana · 2024
DOI: 10.35366/115812 ↗At a glance
Journal article in Acta Ortopédica Mexicana, 2024. Written by W F Martínez and 3 co-authors. Institution: Pontificia Universidad Católica Argentina, Facultad de Medicina. Buenos Aires, Argentina; Grupo GRECARO. Major MEDLINE topics: Vancomycin, Arthroplasty, Replacement, Knee, Anti-Bacterial Agents, Antibiotic Prophylaxis. 27 references.
Abstract (original language)
Introduction
Intravenous antibiotic prophylaxis has significantly reduced the incidence of periprosthetic joint infection (PJI) in knee surgeries. However, for patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) or those at risk of colonization, prophylaxis should include vancomycin. Intraosseous (IO) administration of vancomycin could enhance its effectiveness in total knee arthroplasty (TKA). Material and methods: A retrospective review was conducted, including 143 patients at risk of PJI scheduled for TKA who received IO vancomycin along with intravenous (IV) cefazolin, referred to as group I (GI), between May 2021 and December 2022. The occurrence of complications in the first three postoperative months was evaluated. Results were compared with 140 patients without risk factors who received standard IV prophylaxis, designated as group II (GII).
Results
In GI, 500 mg of IO vancomycin was administered, injected into the proximal tibia, in addition to standard IV prophylaxis. In GII, patients received only IV cefazolin. The incidence of complications was 1.64% in GI and 1.4% in GII. The PJI rate at 90 postoperative days was 0.69% in GI and 0.71% in GII.
Conclusions
IO vancomycin administration, along with standard IV prophylaxis, provides a safe and effective alternative for patients at risk of MRSA colonization. This approach minimizes complications associated with IV vancomycin use and addresses logistical challenges of timely administration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pontificia Universidad Católica Argentina, Facultad de Medicina. Buenos Aires, Argentina; Grupo GRECARO.
- Clínica San Camilo. Ciudad Autónoma de Buenos Aires, Argentina; Grupo GRECARO.
- Instituto de Tratamiento y Rehabilitación Articular, Instituto Argentino de Diagnóstico y Tratamiento. Ciudad Autónoma de Buenos Aires, Argentina; Grupo GRECARO.
- Servicio de Ortopedia y Traumatología, Hospital Británico de Buenos Aires, Instituto Argentino de Diagnóstico y Tratamiento. Ciudad Autónoma de Buenos Aires, Argentina; Grupo GRECARO.
Cite
APA
Martínez, W. F., Tillet, F., Bochatey, E. J., & Lopreite, F. A. (2024). Vancomicina intraósea en artroplastía total de rodilla. Acta Ortopédica Mexicana. https://doi.org/10.35366/115812
Vancouver
Martínez WF, Tillet F, Bochatey EJ, Lopreite FA. Vancomicina intraósea en artroplastía total de rodilla. Acta Ortopédica Mexicana. 2024. doi:10.35366/115812
BibTeX
@article{Martnez2024,
author = {Martínez, W F and Tillet, F and Bochatey, E J and Lopreite, F A},
title = {Vancomicina intraósea en artroplastía total de rodilla},
journal = {Acta Ortopédica Mexicana},
year = {2024},
doi = {10.35366/115812}
}
EUVIMED